scorecardresearch
Follow Us:
Monday, November 30, 2020

Pfizer seeking emergency use of its COVID-19 vaccine in US

The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

By: AP | New York | Updated: November 20, 2020 8:20:50 pm
coronavirus vaccine, coronavirus vaccine status, covid-19 vaccine, covid-19 vaccine latest news, coronavirus vaccine news, covid 19 vaccine update, coronavirus vaccine update, pfizer vaccine news, moderna vaccine, moderna covid 19 vaccine, moderna coronavirus vaccine, Indian express explainedThe Pfizer-BioNTech shot has raced to the head of the line after delays to trials of a vaccine from AstraZeneca Plc and the University of Oxford, which has also shown some promising signs in preliminary results from broad studies.

Pfizer said Friday it is asking US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic — but not until after a long, hard winter.

The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to Friday’s FDA submission, they have already started rolling applications in Europe and the UK and intend to submit similar information soon.

With the coronavirus surging around the US and the world, the pressure is on for regulators to make a speedy decision.

Explained | How effective are the top Covid-19 vaccines, when will they be available

“Help is on the way,” Dr Anthony Fauci, the top US infectious disease expert said on the eve of Pfizer’s announcement, adding that it’s too early to abandon masks and other protective measures. “We need to actually double down on the public health measures as we’re waiting for that help to come.”

Friday’s filing sets off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.

How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed.

About 25 million doses of the Pfizer vaccine may become available in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest World News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement